Zobrazeno 1 - 10
of 269
pro vyhledávání: '"Afshin Borhani-Haghighi"'
Publikováno v:
Heliyon, Vol 10, Iss 14, Pp e34121- (2024)
Stroke is the second leading cause of death and the third leading cause of disability worldwide. Globally, 68 % of all strokes are ischemic, with 32 % being hemorrhagic. Ischemic stroke (IS) poses significant challenges globally, necessitating the de
Externí odkaz:
https://doaj.org/article/2d5ae467465341818372dadcca690227
Autor:
Negin Gharbi, Hamideh Mahmoudinasab, Etrat Hooshmandi, Mousa Rahimi, Mahnaz Bayat, Najmeh Karimi, Seyedeh Shamim Hojati, Zoofa Zayani, Reza Tabrizi, Afshin Borhani-Haghighi
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 25, Iss 1, Pp 1-8 (2024)
Abstract Background Long non-coding RNAs, known as LncRNAs, have demonstrated a robust association with the pathogenesis of stroke. NRON and SNHG are among the most extensively studied lncRNAs in the context of atherosclerosis and inflammatory condit
Externí odkaz:
https://doaj.org/article/6a6ccc49f1864292a984ed11238f4eaf
Autor:
Tahereh Asadabadi, Mohammad Javad Mokhtari, Mahnaz Bayat, Anahid Safari, Afshin Borhani-Haghighi
Publikováno v:
Cell Journal, Vol 25, Iss 12, Pp 863-873 (2023)
Objective: Genetic aspects can play an essential role in the occurrence and development of ischemic stroke (IS).Rs1894720 polymorphism is one of the eight single nucleotide polymorphisms (SNPs) in the long non-coding RNA(lncRNA) myocardial infarction
Externí odkaz:
https://doaj.org/article/0b3300a36734429698451f25aa417b5a
Autor:
Maryam Owjfard, Negin Rahmani, Arashk Mallahzadeh, Mahnaz Bayat, Afshin Borhani-Haghighi, Farzaneh Karimi, Mohammad Reza Namavar
Publikováno v:
Heliyon, Vol 10, Iss 4, Pp e26640- (2024)
Nicorandil is a dual mechanism anti-anginal agent that acts as a nitric oxide (NO) donor and a potassium (K+) channel opener. Recent studies have evaluated the effect of nicorandil on ischemic stroke. Neurons have a low tolerance to hypoxia and there
Externí odkaz:
https://doaj.org/article/34aab71de19d416a8640bc2ebf2a5fa1
Publikováno v:
Iranian Journal of Immunology, Vol 20, Iss 3, Pp 359-367 (2023)
Background: The initial inflammatory reaction starts following occlusion in ischemic stroke (IS). Interleukin-1β (IL-1β) is a pro-inflammatory cytokine with a crucial role in the pathogenesis of neurodegenerative disorders.Objective: To investigate
Externí odkaz:
https://doaj.org/article/96a4e4652f3f468da61d3ac8a226dbf9
Autor:
Behnam Sabayan, Roham Goudarzi, Yuekai Ji, Afshin Borhani‐Haghighi, Barbara A. Olson‐Bullis, Anne M. Murray, Sanaz Sedaghat
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 22 (2023)
Background Intracranial atherosclerosis disease (ICAD) alters cerebrovascular hemodynamics and brain structural integrity. Multiple studies have evaluated the link between ICAD and cognitive impairment, with mixed results. This study aims to systemat
Externí odkaz:
https://doaj.org/article/93fc2d5a3f9e4344a139cdd75735052f
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S201- (2023)
Externí odkaz:
https://doaj.org/article/2bb0aa7926d9481c9a72d350d1660529
Autor:
Nazanin Jalali, Elyar Sadeghi Hokmabadi, Abdoreza Ghoreishi, Payam Sariaslan, Shahram Rafie, Afshin Borhani-Haghighi, Amir Moghadam Ahmadi, Hossein Azin, Alireza Vakilian, Parvin Khalili, Mehdi Farhoudi
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Ischemic stroke is the major form of stroke with two separate vascular territories. Many risk factors are related to stroke outcomes in both territories. The present descriptive research was carried out on the basis of data obtained from the
Externí odkaz:
https://doaj.org/article/4c20b6c778854294b5f0eef813f004c1
Autor:
Afsaneh Vazin, Soha Azadi, Atefeh Jalali, Iman Karimzadeh, Afshin Borhani-Haghighi, Anahid Safari, Fatemeh Mohammadgholizad
Publikováno v:
Trends in Pharmaceutical Sciences, Vol 8, Iss 4, Pp 253-262 (2022)
Stroke-related atrial fibrillation (AF), deep vein thrombosis (DVT), and pulmonary thromboembolism (PE) are among the most common thromboembolic events. recently, direct oral anticoagulants (DOACs) have been slowly replacing warfarin. Rivaroxaban is
Externí odkaz:
https://doaj.org/article/ac22ef678dd54a2bb076f194806060e8
Autor:
Seyedeh Maryam Mousavi, Bijan Akbarpour, Saeideh Karimi-Haghighi, Sareh Pandamooz, Ivaldo Jesus Almeida Belém-Filho, Marianella Masís-Calvo, Haniye Salimi, Ramin Lashanizadegan, Alireza Pouramini, Maryam Owjfard, Etrat Hooshmandi, Mahnaz Bayat, Seyedeh Shaghayegh Zafarmand, Mehdi Dianatpour, Mohammad Saied Salehi, Afshin Borhani-Haghighi
Publikováno v:
BMC Neuroscience, Vol 23, Iss 1, Pp 1-14 (2022)
Abstract Background Stem cell-based therapy has received considerable attention as a potential candidate in the treatment of ischemic stroke; however, employing an appropriate type of stem cells and an effective delivery route are still challenging.
Externí odkaz:
https://doaj.org/article/5f83009cf14a4de8933753ccddfcf907